Lupin Current Affairs, GK & News

Lupin Ltd launched its version of Favipiravir under brand name Covihalt, in India

The Indian Pharmaceuticals major company, Lupin, has launched its version of the antiviral drug Favipiravir to treat the deadly COVI 19 disease. It has been informed by the company in an exchange filing. The drug has been launched with the brand name ‘Covihalt’ for the treatment of mild-to-moderate COVID 19 among the patients. The Drug ..

Month: 

Category: 

Topics: 

Lupin acquires US pharmaceutical firm Gavis

Indian pharmaceutical major Lupin has acquired US based Gavis Pharmaceuticals in cash-free and debt-free transaction for 880 million dollars (around 5,606 crore rupees). In this regard, Lupin has entered into definite agreement with Gavis Pharmaceuticals LLC and its subsidiary Novel Laboratories Inc. This acquisition will help the Indian company to expand and deepen its presence ..

Month: 

Topics: